8-K: AMETEK Reports Record Q3, Raises Full-Year Guidance

AMETEK, Inc. announced record financial results for the third quarter ended September 30, 2025, and subsequently raised its full-year adjusted earnings guidance.

Summary

• Record third quarter 2025 sales reached $1.89 billion, an 11% increase over the third quarter of 2024.
• Adjusted earnings per diluted share were a record $1.89, up 14% from the third quarter of 2024.
• GAAP earnings per diluted share for the quarter were $1.60.
• GAAP operating income was a record $488.4 million, representing 25.8% of sales.
• Adjusted operating income was a record $496.1 million, an 11% increase compared to the prior year's third quarter.
• The Electronic Instruments Group (EIG) reported record sales of $1.25 billion, a 10% increase over the same period in 2024, with adjusted operating income of $360.2 million, up 6%.
• The Electromechanical Group (EMG) achieved record sales of $646.3 million, up 13% from Q3 2024, with operating income increasing 25% to $163.9 million and operating income margins at 25.4%, up 250 basis points.
• Full-year 2025 overall sales are still expected to be up mid-single digits compared to 2024.
• Full-year 2025 adjusted earnings per diluted share guidance was raised to a range of $7.32 to $7.37, an increase of 7% to 8% over 2024, up from the previous guidance of $7.06 to $7.20.
• For the fourth quarter of 2025, overall sales are expected to be up approximately 10%, and adjusted earnings are anticipated to be in the range of $1.90 to $1.95 per share, up 2% to 4% compared to Q4 2024.

Sentiment

Score: 9

Explanation: The filing reports record financial results across multiple key metrics, including sales, adjusted EPS, and operating income. The company also raised its full-year earnings guidance, indicating strong confidence in continued performance. Management commentary is highly positive, emphasizing growth, operational excellence, and successful integration of acquisitions.

Positives

• Achieved record third quarter 2025 sales of $1.89 billion, an 11% increase over Q3 2024.
• Reported record adjusted earnings per diluted share of $1.89, marking a 14% increase from Q3 2024.
• Delivered record GAAP operating income of $488.4 million, representing a strong 25.8% of sales.
• Recorded record adjusted operating income of $496.1 million, an 11% increase year-over-year.
• Achieved an outstanding 90 basis points of margin expansion, excluding the impact of recent acquisitions.
• Electronic Instruments Group (EIG) sales increased 10% to $1.25 billion, with 50 basis points of margin expansion excluding recent acquisitions.
• Electromechanical Group (EMG) sales increased 13% to $646.3 million, with operating income up 25% to $163.9 million and operating income margins at 25.4%, up 250 basis points.
• Raised full-year 2025 adjusted earnings per diluted share guidance to $7.32 $7.37, an increase from the previous range of $7.06 $7.20.
• Expressed satisfaction with the progress of the FARO Technologies integration and excitement for future growth opportunities in the expanded metrology platform.
• Maintains a flexible operating structure, diverse and attractive end market exposures, and strong cash flows, positioning for sustained success.

Risks

• Risks related to the ability to consummate and successfully integrate future acquisitions.
• Risks associated with international sales and operations, including supply chain disruptions, tariffs, trade disputes, and currency conditions.
• The ability to successfully develop new products, open new facilities, or transfer product lines.
• Fluctuations in the price and availability of raw materials.
• Compliance with government regulations, including environmental regulations.
• Changes in the competitive environment or the effects of competition in markets.
• The ability to maintain adequate liquidity and financing sources.
• General economic conditions affecting the industries served.

Future Outlook

Overall sales for 2025 are expected to be up mid-single digits compared to 2024. Adjusted earnings per diluted share for 2025 are now expected to be in the range of $7.32 to $7.37, an increase of 7% to 8% over 2024. For the fourth quarter of 2025, overall sales are expected to be up approximately 10%, and adjusted earnings are anticipated to be in the range of $1.90 to $1.95 per share, up 2% to 4% compared to Q4 2024.

Management Comments

• "AMETEK delivered impressive results in the third quarter, highlighted by double digit growth in sales, orders and earnings per share, along with an outstanding 90 basis points of margin expansion excluding the impact of recent acquisitions." David A. Zapico, AMETEK Chairman and Chief Executive Officer.
• "The strength of the AMETEK Growth Model and the excellent contributions from our colleagues led to record results in the quarter." David A. Zapico.
• "EIG delivered solid results in the quarter with strong profit growth and 50 basis points of margin expansion excluding the impact of recent acquisitions." David A. Zapico.
• "Additionally, we are pleased with the progress of the Faro Technologies integration and excited for the growth opportunities ahead for our expanded metrology platform." David A. Zapico.
• "EMG's third quarter results were outstanding, with broad based sales and orders growth led by Paragon Medical, resulting in record operating income and sizeable margin expansion." David A. Zapico.
• "This performance reflects the strength of our differentiated businesses and our unwavering focus on operational excellence." David A. Zapico.
• "Our businesses performed exceptionally well in the third quarter, delivering strong growth and impressive operating results." David A. Zapico.
• "AMETEKs flexible operating structure, diverse and attractive end market exposures, and strong cash flows position us well for sustained success." David A. Zapico.
• "For 2025, we continue to expect overall sales to be up mid-single digits compared to 2024. Adjusted earnings per diluted share are now expected to be in the range of $7.32 to $7.37, up 7% to 8% over the comparable basis for 2024. This is an increase from our previous guidance range of $7.06 to $7.20." David A. Zapico.
• "For the fourth quarter of 2025, overall sales are expected to be up approximately 10% compared to the same period last year. Adjusted earnings in the quarter are anticipated to be in the range of $1.90 to $1.95 per share, up 2% to 4% compared to the fourth quarter of 2024." David A. Zapico.

Industry Context

AMETEK's strong performance across both its Electronic Instruments Group (EIG) and Electromechanical Group (EMG) suggests robust demand within its diverse niche markets in the industrial technology sector. The successful integration of FARO Technologies and growth led by Paragon Medical highlight effective strategic acquisitions and operational execution. The company's emphasis on a flexible operating structure, diverse end-market exposures, and strong cash flows positions it well within the broader industrial technology landscape, indicating resilience and adaptability to market conditions.

Stakeholder Impact

• Shareholders: Positive impact due to record financial performance, increased earnings, raised guidance, and a focus on double-digit EPS growth and superior return on total capital. Dividends per share increased from $0.28 in Q3 2024 to $0.31 in Q3 2025.
• Employees: Positive impact as 'excellent contributions from our colleagues' are acknowledged as a factor in record results, suggesting a stable and successful company environment.
• Customers: Implied positive impact through 'Technology Innovation' and 'Operational Excellence' leading to better products and services.
• Suppliers: Implied stable relationships given the strong operational performance and growth.

Next Steps

• Host a webcast of the third quarter 2025 investor conference call on Thursday, October 30, 2025, beginning at 8:30 AM ET.
• Continue the integration of FARO Technologies to realize growth opportunities for the expanded metrology platform.
• Execute the AMETEK Growth Model, which integrates Operational Excellence, Technology Innovation, Global and Market Expansion, and Strategic Acquisitions.
• Maintain a disciplined focus on cash generation and capital deployment.
• Work towards the objective of achieving double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital.

Key Dates

Recommendation

The company delivered record financial results for the third quarter, significantly exceeding prior-year performance in sales, adjusted earnings per share, and operating income. Management has raised its full-year adjusted EPS guidance, signaling strong confidence in continued growth. The performance is broad-based across both key segments, with notable margin expansion. The successful integration of acquisitions like FARO Technologies and strong cash generation further enhance the company's financial health and future prospects, making it an attractive investment.

Keywords

AMETEK, AME, Q3 2025, earnings, financial results, guidance, industrial technology, Electronic Instruments Group, Electromechanical Group, operating income, EPS, sales, acquisitions, FARO Technologies, Paragon Medical